{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:23:15Z","timestamp":1790392995941,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/mt.2015.147","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T11:58:07Z","timestamp":1439812687000},"page":"1772-1782","source":"Crossref","is-referenced-by-count":70,"title":["Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Jia-Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsaiyu","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guann-Gen","family":"Chern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ts-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.147_bib1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hep.26790","article-title":"Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha\/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"10.1038\/mt.2015.147_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez\u2013Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2015.147_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.21758","article-title":"Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients","volume":"46","author":"Hui","year":"2007","journal-title":"Hepatology"},{"key":"10.1038\/mt.2015.147_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver\u2013linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1038\/mt.2015.147_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/SLA.0b013e3181f9bc00","article-title":"Gene expression signature of the gross morphology in hepatocellular carcinoma","volume":"253","author":"Murakata","year":"2011","journal-title":"Ann Surg"},{"key":"10.1038\/mt.2015.147_bib6","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.26122","article-title":"Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance","volume":"57","author":"Sato","year":"2013","journal-title":"Hepatology"},{"key":"10.1038\/mt.2015.147_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jhep.2004.09.006","article-title":"Angiogenesis and hepatocellular carcinoma","volume":"41","author":"Semela","year":"2004","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2015.147_bib8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.1125950","article-title":"Antiangiogenic therapy: a universal chemosensitization strategy for cancer?","volume":"312","author":"Kerbel","year":"2006","journal-title":"Science"},{"key":"10.1038\/mt.2015.147_bib9","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1021\/nn100448z","article-title":"Potent angiogenesis inhibition by the particulate form of fullerene derivatives","volume":"4","author":"Meng","year":"2010","journal-title":"ACS Nano"},{"key":"10.1038\/mt.2015.147_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","article-title":"HCC and angiogenesis: possible targets and future directions","volume":"8","author":"Zhu","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/mt.2015.147_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0076-6879(05)07047-3","article-title":"Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF\/MEK\/ERK pathway in tumor cells and tyrosine kinases VEGFR\/PDGFR in tumor vasculature","volume":"407","author":"Adnane","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1038\/mt.2015.147_bib12","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.147_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.147_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1665-2681(19)31886-1","article-title":"Sorafenib, a systemic therapy for hepatocellular carcinoma","volume":"7","author":"M\u00e9ndez-S\u00e1nchez","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1038\/mt.2015.147_bib15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s10620-012-2136-1","article-title":"Sorafenib for treatment of hepatocellular carcinoma: a systematic review","volume":"57","author":"Xie","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1038\/mt.2015.147_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2015.147_bib17","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.147_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1038\/mt.2015.147_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/15680096113136660107","article-title":"Role of inflammation-associated microenvironment in tumorigenesis and metastasis","volume":"14","author":"Gao","year":"2014","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1038\/mt.2015.147_bib20","doi-asserted-by":"crossref","first-page":"C987","DOI":"10.1152\/ajpcell.00406.2006","article-title":"Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis","volume":"292","author":"Kryczek","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/mt.2015.147_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jhep.2012.06.012","article-title":"Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma","volume":"57","author":"Gentilini","year":"2012","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2015.147_bib22","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1038\/mt.2015.147_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2407-9-176","article-title":"Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival","volume":"9","author":"Xiang","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1038\/mt.2015.147_bib24","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1038\/bcj.2011.13","article-title":"AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo","volume":"1","author":"Yu","year":"2011","journal-title":"Blood Cancer J"},{"key":"10.1038\/mt.2015.147_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1593\/neo.12324","article-title":"CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy","volume":"14","author":"Domanska","year":"2012","journal-title":"Neoplasia"},{"key":"10.1038\/mt.2015.147_bib26","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.147_bib27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hep.27665","article-title":"CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"10.1038\/mt.2015.147_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1038\/mt.2015.147_bib29","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.147_bib30","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/0008-5472.CAN-13-1989","article-title":"Benefits of vascular normalization are dose and time dependent\u2013letter","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.147_bib31","doi-asserted-by":"crossref","first-page":"187204","DOI":"10.1155\/2013\/187204","article-title":"The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages","volume":"2013","author":"Capece","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1038\/mt.2015.147_bib32","doi-asserted-by":"crossref","first-page":"E318","DOI":"10.1111\/hepr.12260","article-title":"Novel therapeutic target of hepatocellular carcinoma by manipulation of macrophage colony-stimulating factor\/tumor-associated macrophages axis in tumor microenvironment","volume":"44","author":"Zhou","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1038\/mt.2015.147_bib33","first-page":"2025","article-title":"Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay","volume":"45","author":"Tofilon","year":"1985","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.147_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1269\/jrr.10185","article-title":"A novel combination treatment of armed oncolytic adenovirus expressing IL-12 and GM-CSF with radiotherapy in murine hepatocarcinoma","volume":"52","author":"Kim","year":"2011","journal-title":"J Radiat Res"},{"key":"10.1038\/mt.2015.147_bib35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/mt.2009.291","article-title":"Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy","volume":"18","author":"Chen","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.147_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/mp049907k","article-title":"Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier","volume":"2","author":"Cui","year":"2005","journal-title":"Mol Pharm"},{"key":"10.1038\/mt.2015.147_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.mt.6300323","article-title":"Tumor-targeted delivery of siRNA by self-assembled nanoparticles","volume":"16","author":"Li","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.147_bib38","doi-asserted-by":"crossref","first-page":"35337","DOI":"10.1074\/jbc.M803342200","article-title":"Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta)","volume":"283","author":"Clifford","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2015.147_bib39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1440-169X.2008.01052.x","article-title":"In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation","volume":"50","author":"Kim","year":"2008","journal-title":"Dev Growth Differ"},{"key":"10.1038\/mt.2015.147_bib40","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1538-7836.2007.02603.x","article-title":"Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells","volume":"5","author":"Albrektsen","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T15:34:48Z","timestamp":1718033688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1525001616301885"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.147","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}